Botulinum toxin type A improves blood flow in vascular thoracic outlet syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18936559.
- Also identified by DOI 10.1097/PHM.0b013e31818a51c3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 28-yr-old man, diagnosed with vascular thoracic outlet syndrome, had his right anterior scalene muscle injected with botulinum toxin type A under ultrasound guidance. Subclavian artery flow rates were measured with Doppler ultrasound before and 3 wks after the injection. At 3 wks, symptoms had improved. The reduction in subclavian artery flow rate associated with the arm abducted to the side with 90-degree external rotation decreased from 132.8 to 87.7 cm/sec preinjection compared with a smaller decrease postinjection from 132.8 to 119.1 cm/sec. An improved subclavian artery flow was seen after scalene muscle chemodenervation for vascular thoracic outlet syndrome. This suggests its potential as a diagnostic test, treatment option, and predictor for surgical intervention.
Medical subject headings
- Botulinum Toxins, Type A
- Neck Muscles
- Neuromuscular Agents
- Thoracic Outlet Syndrome